University of Louisville
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Louisville sits in the top decile of US sponsors by registered trial count (#149 of 15,742 sponsors by registered trial count).
University of Louisville: 217 sponsored US clinical trials, 46 recruiting.
University of Louisville sponsors 217 registered US clinical trials on ClinicalTrials.gov, 46 of them currently recruiting, and 132 completed. 26 of these trials are in Phase 3-4 (later-stage) and 42 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spinal Cord Injuries, with 9 trials.
Top-decile sponsor footprint
University of Louisville ranks in the top decile of sponsors by registered trial count (#149 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
132 of 158 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
217 total, page 5 of 5
Clinical Trial of New Elastomer for Maxillofacial Prosthetics
NCT00123097
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
NCT00265200
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
NCT00268151
Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients
NCT00116584
Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis
NCT00264082
A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.
NCT00605930
Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome
NCT00560586
Human Papilloma Virus DNA Self-Test
NCT00266266
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
NCT00683631
Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
NCT00456989
Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
NCT00708513
Prognostic Markers of Gynecologic Cancers
NCT00290459
Racial Disparity in Endometrial Cancer
NCT00375804
Treatment of Depression in Nursing Homes
NCT00056485
Ovarian Screening Study
NCT00267072
rhGH Therapy on Hepatic Drug Metabolism
NCT00458991
Minimally Invasive Radioguided Parathyroidectomy
NCT01530919
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 21 |
| Phase 3 | 3 |
| Phase 4 | 23 |
What is open in the University of Louisville pipeline
46 recruiting of 217 indexed (21% open); 132 completed (61%).
Phase mix: 26 late (III/IV) vs 42 early (I/II) (early-phase heavy).
Top condition: Spinal Cord Injuries (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Louisville: open-pipeline peers nationwide
Peers matched on 217 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Louisville sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 217 trials (± recruiting share)
- Florida State University · 219 trials · 21% recruiting
- Penn State University · 219 trials · 17% recruiting
- National Eye Institute (NEI) · 221 trials · 8% recruiting
- Otsuka Pharmaceutical Development & Commercialization · 221 trials · 4% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Ohio State University · 21% recruiting · 552 trials
- Medical College of Wisconsin · 21% recruiting · 447 trials
- Nova Southeastern University · 21% recruiting · 71 trials
- Colorado State University · 21% recruiting · 94 trials
Related
What to do with this University of Louisville page
217 registered trials is a research-attention snapshot, not an endorsement of University of Louisville or any single study.
- 46 of University of Louisville's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Spinal Cord Injuries is the condition University of Louisville studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spinal Cord Injuries trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Louisville pipeline card: 217 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.